The conventional titration pattern ramps up to a 4 mg, 8 mg, or 12 mg maintenance dose after the 12-week introduction
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
The four standard sites all work, but the questions patients actually ask are whether to inject near the injury, how to rotate, and how to do it without a stinging welt
Read More Histamine intolerance is often mistaken for allergies or IBS
BPC-157 works the other way around: a slower, regenerative approach taken as a daily injection over weeks
Normal B12 levels are 400 picograms per milliliter